Navigation Links
Novel Technique Can Enhance Stem Cell Multiplication By 30 Fold

A novel method which can aid in the multiplication of adult stem cells, yielding a 30 fold enhanced harvest has been discovered.// This finding could eventually pave way for the development of refinement in bone transplantation and gene therapy techniques.

The use of adult stem cells is encouraged to a great extent as it is associated with less ethical concerns and surpasses the utilization of human embryos, generated for reproductive purposes. However, a number of scientific challenges have to be overcome before these cells can be maximally exploited.

Technical aspects related to the isolation and in-vivo culture of adult stem cells is still in its infancy. Signals that induce the differentiation of adult stem cells into are poorly understood. The limited availability of adult stem cells in human tissues is also a major limiting factor.

The researchers of the present study were determined to develop an effective mechanism to accelerate the multiplication process following isolation from tissue. Hematopoietic stem cells (derived from fetal tissue of mice), capable of giving rise to blood cell components and cells of the immune system were taken up for the study.

The researchers were able to identify a specialized group of cells (different from stem cells) from the isolate. The stem cells were found to be dependent on the newly discovered cells for their growth and multiplication. The stem cells died when they were placed in an environment devoid of these cells. Based on this striking observation, the researchers began to look for specific gene expressions that were active in the new cell population.

It was hypothesized that such genes could code for growth factors or other similar substances, critical for stem cell growth and multiplication. The researchers employed microarray technique to locate such genes. One such identified component was Insulin like growth factor (IGF-2). A 8-fold increase in the stem cell population was observed when the hematopoietic cells were mixed with purified IGF-2.

Abundant expression of two other factors called Angiopoietin-like 2 (angpt12) and Angiopoietin-like –3 (angpt13) were also found. When these components were mixed with IGF-2, a 30-fold increase in the stem cell multiplication could be seen.

Stem cell therapy in the form of bone marrow transplantation remains a viable, life-saving option for patients with hematological malignancies. The stem cells can either be obtained from the bone marrow or even cord blood, though the latter is most commonly used. If this finding can be applied to the isolate, then perhaps, we could have adequate stem cells to treat a particular patient.

Gene therapy is yet another area, where the above finding can be useful. Issues related to the possibility of carcinogenesis as a consequence of gene therapy has to a large extent restricted the approval of any gene-therapy clinical trials.

The study has led to an improved understanding of the stem cell biology, stem cell therapy and research. The researchers are further interested in knowing whether similar results can be obtained for human cord blood as well.
'"/>




Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel test for bowel cancer
7. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
8. Novel Therapy for Chronic Problem
9. Blood Sugar Kept In Control By Novel Protein
10. Novel antibiotic dressing developed for improved wound healing
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2017)... Fairfax, VA (PRWEB) , ... May 26, 2017 ... ... is pleased to announce a new educational seminar to focus on current legislative ... Regulatory News(LEARN) seminar will begin at 1 p.m. Sunday, Sept. 10, and will ...
(Date:5/26/2017)... ... May 26, 2017 , ... ... copper, antimicrobial, mesh back 24/7 task chair specifically designed for clinical areas. Genie ... are thrilled to partner with Cupron® to provide customers with a game changing ...
(Date:5/26/2017)... , ... May 26, 2017 , ... Rob Lowe acts ... upcoming production of the series is on hiking in American. Viewers can reconnect with ... the great benefits of hiking. , Many consumers have looked for an inventive new ...
(Date:5/26/2017)... ... ... “Just What Happened in the Garden of Eden”: retells the stories of three Bible figures ... of published author, Penelope Colt, mother, trader, horse farmer, artist and a former GM journeyman. ... three. At six, they moved to Dayton, Ohio, where Penny graduated high school. ...
(Date:5/24/2017)... ... May 24, 2017 , ... Dr. Alan I. Benvenisty, MD is dual board ... He is known for his distinguished expertise and experience in the diagnosis and treatment ... training in treating renovascular disease and aortic aneurysm . He is known for ...
Breaking Medicine News(10 mins):
(Date:5/9/2017)... 9, 2017  Semler Scientific, Inc. (OTCQB: SMLR), ... to improve the clinical effectiveness and efficiency of ... first quarter ended March 31, 2017. ... customers to identify when preventive care options are ... like heart attacks or strokes occur," said ...
(Date:5/6/2017)... Provista , a proven leader in the supply chain industry ... Jim Cunniff as the company,s new president and CEO. ... Provista, including most recently serving as the president and CEO ... He assumed his new role with Provista on May 1, ... says Jody Hatcher , president, Sourcing and Collaboration Services ...
(Date:5/4/2017)... 4, 2017  Fortuna Fix Inc. (" Fortuna "), ... first to eliminate the need for embryonic and fetal stem ... neurodegenerative diseases. Fortuna announced today the ... Michael Fehlings , MD, PhD; Father Kevin FitzGerald , ... and Professor James Giordano , PhD. "We ...
Breaking Medicine Technology: